Novel Flurbiprofen Derivatives as Antioxidant and Anti-Inflammatory Agents: Synthesis, In Silico, and In Vitro Biological Evaluation

Iliyan Ivanov,Stanimir Manolov,Dimitar Bojilov,Gabriel Marc,Diyana Dimitrova,Smaranda Oniga,Ovidiu Oniga,Paraskev Nedialkov,Maria Stoyanova

DOI: https://doi.org/10.3390/molecules29020385

IF: 4.6

2024-01-13

Molecules

Abstract:In this study, we present the synthesis of five novel compounds by combining flurbiprofen with various substituted 2-phenethylamines. The synthesized derivatives underwent comprehensive characterization using techniques such as 1H- and 13C-NMR spectroscopy, UV-Vis spectroscopy, and high-resolution mass spectrometry (HRMS). Detailed HRMS analysis was performed for each of these newly created molecules. The biological activities of these compounds were assessed through in vitro experiments to evaluate their potential as anti-inflammatory and antioxidant agents. Furthermore, the lipophilicity of these derivatives was determined, both theoretically using the cLogP method and experimentally through partition coefficient (RM) measurements. To gain insights into their binding affinity, we conducted an in silico analysis of the compounds' interactions with human serum albumin (HSA) using molecular docking studies. Our findings reveal that all of the newly synthesized compounds exhibit significant anti-inflammatory and antioxidant activities, with results statistically comparable to the reference compounds. Molecular docking studies further explain the observed in vitro results, shedding light on the molecular mechanisms behind their biological activities. Using in silico method, toxicity was calculated, resulting in LD50 values. Depending on the administration route, the novel flurbiprofen derivatives show lower toxicity compared to the standard flurbiprofen.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper aims to address the problem of developing new flurbiprofen derivatives to optimize their pharmacokinetics, bioavailability, and safety while maintaining their anti-inflammatory and antioxidant activities. Specifically, the study synthesized five new amide derivatives by combining flurbiprofen with different 2-phenylethylamines and conducted detailed in vitro biological evaluations and molecular docking analyses of these derivatives. The main objectives of the study include:

1. **Synthesis of new flurbiprofen derivatives**: Preparation of five new flurbiprofen amide derivatives through chemical synthesis methods.
2. **Characterization of new compounds**: Structural characterization of the new compounds using techniques such as Nuclear Magnetic Resonance (NMR), Ultraviolet-Visible Spectroscopy (UV-Vis), and High-Resolution Mass Spectrometry (HRMS).
3. **Evaluation of biological activity**: Assessment of the antioxidant and anti-inflammatory activities of these derivatives through in vitro experiments, comparing them with standard drugs (such as flurbiprofen).
4. **Molecular docking analysis**: Understanding the binding affinity of these compounds with human serum albumin (HSA) through molecular docking studies to reveal their molecular mechanisms.
5. **Evaluation of lipophilicity and toxicity**: Determination of the lipophilicity of these derivatives through theoretical calculations (cLogP) and experimental measurements (partition coefficient), and calculation of their toxicity (LD50 values).

Through these comprehensive studies, the paper aims to develop new flurbiprofen derivatives with higher efficacy and lower toxicity to overcome the limitations of existing flurbiprofen in clinical applications.